Singapore markets close in 2 hours 26 minutes
Straits Times Index
3,289.50 +23.55 (+0.72%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,930.85 +393.04 (+2.12%) FTSE 100
8,381.35 +27.30 (+0.33%) Bitcoin USD
62,821.12 +1,120.19 (+1.82%) CMC Crypto 200
1,352.73 -5.28 (-0.39%)
Keros Therapeutics, Inc. (KROS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.08B |
| Enterprise value | 1.66B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.72k |
| Price/book (mrq) | 4.59 |
| Enterprise value/revenue | 7.08k |
| Enterprise value/EBITDA | -9.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.32 |
| 52-week change 3 | 28.11% |
| S&P500 52-week change 3 | 26.43% |
| 52-week high 3 | 73.00 |
| 52-week low 3 | 27.02 |
| 50-day moving average 3 | 62.59 |
| 200-day moving average 3 | 45.07 |
Share statistics
| Avg vol (3-month) 3 | 347.23k |
| Avg vol (10-day) 3 | 298.09k |
| Shares outstanding 5 | 36.08M |
| Implied shares outstanding 6 | 36.38M |
| Float 8 | 30.94M |
| % held by insiders 1 | 6.36% |
| % held by institutions 1 | 87.88% |
| Shares short (15 Apr 2024) 4 | 2.26M |
| Short ratio (15 Apr 2024) 4 | 6.49 |
| Short % of float (15 Apr 2024) 4 | 8.92% |
| Short % of shares outstanding (15 Apr 2024) 4 | 6.26% |
| Shares short (prior month 15 Mar 2024) 4 | 1.92M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -58,413.26% |
Management effectiveness
| Return on assets (ttm) | -25.79% |
| Return on equity (ttm) | -39.63% |
Income statement
| Revenue (ttm) | 234k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -178.63M |
| Net income avi to common (ttm) | -160.3M |
| Diluted EPS (ttm) | -5.15 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 442.44M |
| Total cash per share (mrq) | 12.26 |
| Total debt (mrq) | 14.2M |
| Total debt/equity (mrq) | 3.13% |
| Current ratio (mrq) | 24.74 |
| Book value per share (mrq) | 12.59 |
Cash flow statement
| Operating cash flow (ttm) | -134.83M |
| Levered free cash flow (ttm) | -90.18M |
© 2024 Yahoo. All rights reserved.